Health Novel Anti-CD40L Antibody Slows New Brain Lesions in Relapsing MS Posted on February 15, 2024 by miyuru Neurology > Several Sclerosis — Frexalimab reveals guarantee in stage II research study by Judy GeorgeDeputy Managing Editor, MedPage Today February 14, 2024 Frexalimab, an investigational second-generation CD40 ligand (CD40L)….
